Global Infusion Therapy Devices Market 2019-2023

輸液療法装置の世界市場2019-2023

◆タイトル:Global Infusion Therapy Devices Market 2019-2023
◆商品コード:IRTNTR31309
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年5月17日
◆ページ数:149
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:Health Care
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、輸液療法装置の世界市場について調査・分析し、市場概要、市場環境、輸液療法装置市場規模、製品別(アクセサリーと消耗品、ポンプ)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・輸液療法装置の世界市場概要
・輸液療法装置の世界市場環境
・輸液療法装置の世界市場動向
・輸液療法装置の世界市場規模
・輸液療法装置の世界市場:業界構造分析
・輸液療法装置の世界市場:製品別(アクセサリーと消耗品、ポンプ)
・輸液療法装置の世界市場:地域別市場規模・分析
・輸液療法装置の北米市場規模・予測
・輸液療法装置のヨーロッパ・中東・アフリカ市場規模・予測
・輸液療法装置のアジア太平洋市場規模・予測
・輸液療法装置の主要国分析
・輸液療法装置の世界市場:意思決定フレームワーク
・輸液療法装置の世界市場:成長要因、課題
・輸液療法装置の世界市場:競争環境
・輸液療法装置の世界市場:関連企業情報(ベンダー分析)

About this market

The growing number of surgical process is one of the critical factors that will trigger the growth of the infusion therapy devices market. Surgical procedures comprise manual and instrumental medical intervention, which are usually performed in ASCs and hospital clinical settings under anesthesia and with the aid of respiratory devices. Surgical procedures can be performed either in inpatient or outpatient settings. The growing number of outpatient and ambulatory surgeries and the increasing number of people with diseases such as cancer contribute to the growth of the global infusion therapy devices market. Infusion therapy devices are an important therapeutic tool to deliver medications continuously in critical care and pain management situations. The number of surgical procedures performed every year worldwide has increased over the last decade due to the rising prevalence of several diseases. Thus, the increase in the number of surgical procedures during the forecast period will drive the growth of the global infusion therapy devices market during the forecast period. Technavio’s analysts have predicted that the infusion therapy devices market will register a CAGR of 6% by 2023.

Market Overview

Growing aged population and chronic disease prevalence

The increasing life expectancy among people and the prevalence of chronic diseases such as diabetes, cardiovascular, kidney disease, and cancer are contributing to the demand or infusion therapy devices. The number of people with chronic diseases is increasing owing to the sedentary lifestyle, environmental issues, alcohol consumption, lack of physical activity, smoking, and unhealthy eating habits. The aging of the baby boomer generation and increasing prevalence of chronic diseases make the early diagnosis of diseases and the regular monitoring of patients essential to identify, treat, control, and limit the incidence of diseases. Thus, there is a high demand for infusion pumps to provide continuous medication and blood components for critically ill chronic patients. Therefore, the increasing aging of the population and the prevalence of chronic diseases drive the demand for global infusion therapy devices.

High cost of infusion therapy devices

The high cost of infusion therapy devices is one of the major concerns as most patients are unable to afford these devices. With the advances in infusion therapy devices, the cost of devices and treatment is also increasing. The cost includes physician fees, the type of infusion therapy device used, availability of inbuilt features like dose-error reduction software (DERS), and the amount reimbursed for such devices by Mediclaim. The high initial cost of infusion therapy devices, as well as their steep maintenance costs, make them inaccessible and unaffordable in hospitals and primary healthcare centers. Considering all these factors, this is expected to have an adverse impact on the market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the infusion therapy devices market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented. The presence of several companies, including B. Braun Melsungen AG and Becton Dickinson and Co. makes the competitive environment quite intense. Factors such as the growing aged population and chronic illness prevalence and the increasing number of surgical procedures will provide significant growth opportunities to infusion therapy devices manufacturers. F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, ICU Medical Inc., Medtronic, and Terumo Corp. are some of the major companies covered in this report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Accessories and consumables – Market size and forecast 2018-2023

Pumps – Market size and forecast 2018-2023

Market opportunity by product

PART 07: MARKET SEGMENTATION BY INFUSION TYPE

Market segmentation by infusion type

Comparison by infusion type

Continuous infusion – Market size and forecast 2018-2023

Intermittent infusion – Market size and forecast 2018-2023

Infusion-on-demand – Market size and forecast 2018-2023

Total parenteral infusion – Market size and forecast 2018-2023

Market opportunity by infusion type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 12: MARKET TRENDS

Emergence of smart infusion therapy devices

Technological advances

Increasing consumer preference for disposable infusion pumps

PART 13: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 14: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

B. Braun Melsungen AG

Becton Dickinson and Co.

F. Hoffmann-La Roche Ltd.

Fresenius Kabi AG

ICU Medical Inc.

Medtronic

Terumo Corp.

PART 15: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

Exhibit 01: Global medical devices market

Exhibit 02: Segments of global medical devices market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Product – Market share 2018-2023 (%)

Exhibit 18: Comparison by product

Exhibit 19: Accessories and consumables – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: Accessories and consumables – Year-over-year growth 2019-2023 (%)

Exhibit 21: Pumps – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Pumps – Year-over-year growth 2019-2023 (%)

Exhibit 23: Volumetric pumps – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Volumetric pumps – Year-over-year growth 2019-2023 (%)

Exhibit 25: Syringe pumps – Market size and forecast 2018-2023 ($ millions)

Exhibit 26: Syringe pumps – Year-over-year growth 2019-2023 (%)

Exhibit 27: Insulin pumps – Market size and forecast 2018-2023 ($ millions)

Exhibit 28: Insulin pumps – Year-over-year growth 2019-2023 (%)

Exhibit 29: Ambulatory pumps – Market size and forecast 2018-2023 ($ millions)

Exhibit 30: Ambulatory pumps – Year-over-year growth 2019-2023 (%)

Exhibit 31: Other pumps – Market size and forecast 2018-2023 ($ millions)

Exhibit 32: Other pumps – Year-over-year growth 2019-2023 (%)

Exhibit 33: Market opportunity by product

Exhibit 34: Infusion type – Market share 2018-2023 (%)

Exhibit 35: Comparison by infusion type

Exhibit 36: Continuous infusion – Market size and forecast 2018-2023 ($ millions)

Exhibit 37: Continuous infusion – Year-over-year growth 2019-2023 (%)

Exhibit 38: Intermittent infusion – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: Intermittent infusion – Year-over-year growth 2019-2023 (%)

Exhibit 40: Infusion-on-demand – Market size and forecast 2018-2023 ($ millions)

Exhibit 41: Infusion-on-demand – Year-over-year growth 2019-2023 (%)

Exhibit 42: Total parenteral infusion – Market size and forecast 2018-2023 ($ millions)

Exhibit 43: Total parenteral infusion – Year-over-year growth 2019-2023 (%)

Exhibit 44: Market opportunity by infusion type

Exhibit 45: Customer landscape

Exhibit 46: Market share by geography 2018-2023 (%)

Exhibit 47: Geographic comparison

Exhibit 48: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 49: North America – Year-over-year growth 2019-2023 (%)

Exhibit 50: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 51: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 52: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 53: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 54: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 55: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 56: Key leading countries

Exhibit 57: Market opportunity

Exhibit 58: Impact of drivers and challenges

Exhibit 59: Vendor landscape

Exhibit 60: Landscape disruption

Exhibit 61: Vendors covered

Exhibit 62: Vendor classification

Exhibit 63: Market positioning of vendors

Exhibit 64: B. Braun Melsungen AG – Vendor overview

Exhibit 65: B. Braun Melsungen AG – Business segments

Exhibit 66: B. Braun Melsungen AG – Organizational developments

Exhibit 67: B. Braun Melsungen AG – Geographic focus

Exhibit 68: B. Braun Melsungen AG – Segment focus

Exhibit 69: B. Braun Melsungen AG – Key offerings

Exhibit 70: Becton Dickinson and Co. – Vendor overview

Exhibit 71: Becton Dickinson and Co. – Business segments

Exhibit 72: Becton Dickinson and Co. – Organizational developments

Exhibit 73: Becton Dickinson and Co. – Geographic focus

Exhibit 74: Becton Dickinson and Co. – Segment focus

Exhibit 75: Becton Dickinson and Co. – Key offerings

Exhibit 76: F. Hoffmann-La Roche Ltd. – Vendor overview

Exhibit 77: F. Hoffmann-La Roche Ltd. – Business segments

Exhibit 78: F. Hoffmann-La Roche Ltd. – Organizational developments

Exhibit 79: F. Hoffmann-La Roche Ltd. – Geographic focus

Exhibit 80: F. Hoffmann-La Roche Ltd. – Segment focus

Exhibit 81: F. Hoffmann-La Roche Ltd. – Key offerings

Exhibit 82: Fresenius Kabi AG – Vendor overview

Exhibit 83: Fresenius Kabi AG – Business segments

Exhibit 84: Fresenius Kabi AG – Organizational developments

Exhibit 85: Fresenius Kabi AG – Geographic focus

Exhibit 86: Fresenius Kabi AG – Segment focus

Exhibit 87: Fresenius Kabi AG – Key offerings

Exhibit 88: ICU Medical Inc. – Vendor overview

Exhibit 89: ICU Medical Inc. – Product segments

Exhibit 90: ICU Medical Inc. – Organizational developments

Exhibit 91: ICU Medical Inc. – Geographic focus

Exhibit 92: ICU Medical Inc. – Segment focus

Exhibit 93: ICU Medical Inc. – Key offerings

Exhibit 94: Medtronic – Vendor overview

Exhibit 95: Medtronic – Business segments

Exhibit 96: Medtronic – Organizational developments

Exhibit 97: Medtronic – Geographic focus

Exhibit 98: Medtronic – Segment focus

Exhibit 99: Medtronic – Key offerings

Exhibit 100: Terumo Corp. – Vendor overview

Exhibit 101: Terumo Corp. – Business segments

Exhibit 102: Terumo Corp. – Organizational developments

Exhibit 103: Terumo Corp. – Geographic focus

Exhibit 104: Terumo Corp. – Segment focus

Exhibit 105: Terumo Corp. – Key offerings

Exhibit 106: Validation techniques employed for market sizing

Exhibit 107: Definition of market positioning of vendors



【掲載企業】

B. Braun Melsungen AG、Becton Dickinson and Co.、F. Hoffmann-La Roche Ltd.、Fresenius Kabi AG、ICU Medical Inc.、Medtronic、Terumo Corp.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[輸液療法装置の世界市場2019-2023]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆